Shifting Gears: Transitioning from Ad Hoc to Proactive Privacy
Data privacy: A C-suite issue with high stakes
Building an AI model can require large amounts of data about people, and this data needs to be appropriately handled and managed. To protect the privacy of people in the data, anonymized data can be ...
In 2024, we shared several short articles about de-identified or anonymized data. Here, we take a look at how they intersect.
If you’ve been involved in anonymization projects (such as Expert Determinations under HIPAA), you may have been asked to describe the data context in detail: how the data will be used, where it will ...
Unstructured data sources—including text, images, audio, and video—are rich sources of information. They can drive technological innovation and power diverse use cases such as synthetic data ...
Across industries, demand for medical images is on the rise. This is due to increased use cases, such as AI, which can support applications for diagnostics, tracking disease progression, and planning ...
Many organizations are familiar with statistical assessments of identifiability, like Expert Determinations under HIPAA or anonymization assessments under other regulations like the GPDR. In these ...
In the evolving landscape of data enablement, the need to leverage data for driving efficiency, spurring innovation, and fostering collaboration has never been greater. This pursuit should be ...
I wrote in our September newsletter about how trial sponsors are well advised to view transparency as much more than just a box that has to be checked off. This time, I would like to dig deeper into ...
Privacy Analytics is wholly committed to the global effort to respond to COVID-19. We have the collective will, the personal urgency and the technical ability to make a meaningful difference in the ...
I recently heard something that stuck with me: “Nobody complies their way to greatness.” An interesting comment, and a relevant one for all of us in the clinical trial transparency domain. But is ...
Should sponsors integrate risk-based anonymization across both documents and structured individual patient data (S-IPD)?
Unstructured data, such as medical notes, pose unique challenges with regards to anonymization. Not having a traditional database means that you can’t point a software solution to it to transform ...
Health Canada has introduced new regulatory guidance for anonymizing clinical study reports. As background, Bill C-17 Protecting Canadians from Unsafe Drugs Act (Vanessa’s Law) was initiated to ...
Privacy Rights in the Digital Era was the headline theme for this event. The Institute for Humane Studies co-sponsored the event with the Program on Economics & Privacy at George Mason ...
“Making healthcare big data & AI work for everyone, every day” was held on November 21 2018 at Au Premier in Zürich, Switzerland.
METHODOLOGY
Presented by Corinium Global Intelligence, and sponsored in part by Privacy Analytics, among a distinguished list of global organizations, this CDAO Conference was focused on evaluating the role of ...
HITRUST 2018 is the only event dedicated to exploring all aspects of risk management, information security, privacy and utilization of the HITRUST CSF® and HITRUST CSF Assurance Program. This year’s ...
Privacy Analytics is pleased to partner with Vivli: a new, groundbreaking digital platform where researchers can request and analyze clinical trial data sets in a secure research environment.
Filter by Data Type
Categories
